Johnson & JohnsonvsNatera

JNJ and NTRA stock compared: price, dividend, valuation and results, from SEC filings.

Johnson & Johnson (JNJ) has a market value of $639B and Natera (NTRA) $42.2B. Over the last year, with dividends, JNJ moved +35.6% and NTRA +39.3%. Dividend yield: JNJ 1.99%, NTRA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$639B

    NTRA$42.2B

    JNJ is 15 times NTRA

  • Revenue, 12 months

    JNJ$99.3B

    NTRA$2.9B

    JNJ is 34 times NTRA

  • Net income, 12 months

    JNJ$16.1B

    NTRA-$165M

  • Operating margin

    JNJ–

    NTRA-9.0%

  • ROIC

    JNJ12.4%

    NTRA-11.7%

    24.0 points apart

  • P/E

    JNJ39.7

    NTRA–

  • Dividend yield

    JNJ2.0%

    NTRA0.0%

    2.0 points apart

  • 5-year return

    JNJ+87.7%

    NTRA+183.3%

    95.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+87.7%

NTRA+183.2%

20040020222023202420252026
Returns by period
PeriodJNJWith dividendsNTRAWith dividends
1 year since November 18, 2025+35.6%Price +32.6%+39.3%Price +39.3%
3 years since November 17, 2023+92.8%+24.5% a yearPrice +77.0%+456.1%+77.2% a yearPrice +456.1%
5 years since November 18, 2021+87.7%+13.4% a yearPrice +63.3%+183.3%+23.1% a yearPrice +183.3%
10 years since November 21, 2016+200.5%+11.6% a yearPrice +130.6%+2,380.3%+37.9% a yearPrice +2,380.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonNTRANatera

Valuation

JNJNTRA
Valuation
Price$265.15$297.64
Market value$639B$42.2B
Enterprise value (EV)$666B$41.2B
P/E39.7–
P/E, 5-year median21.9–
P/B7.822.6
EV/EBIT37.6–
Free cash flow yield3.2%0.1%

Results and growth

JNJNTRA
Results and growth
Revenue, 12 months$99.3B$2.9B
Net income, 12 months$16.1B-$165M
Free cash flow, 12 months$20.6B$52M
Earnings per share, 12 months$6.59-$1.13
Revenue growth, year on year6.1%35.9%
Revenue growth a year, past+2.7%over 5 years+42.6%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJNTRA
Margins and returns on capital
Gross margin67.6%–
Operating margin–-9.0%
Net margin16.2%-5.7%
ROIC12.4%-11.7%
ROE19.7%-9.8%

Balance sheet

JNJNTRA
Balance sheet
Cash$17.2B$1.1B
Total debt$44.7B$239M
Net debt / EBITDA1.1–
Interest cover18.0×-70.9×

Dividends and buybacks

JNJNTRA
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or NTRA

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Natera?

By market value, Johnson & Johnson ($639B) is about 15.1 times Natera ($42.2B), at today's prices.

How did JNJ and NTRA stock do over the last 10 years?

Since November 21, 2016, JNJ's price moved +130.6% and NTRA's +2,380.3%. With dividends: JNJ +200.5% (+11.6% a year), NTRA +2,380.3% (+37.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or NTRA?

The dividend yield at today's price is 1.99% for Johnson & Johnson and none for Natera. Over the last twelve months they paid $5.28 and – per share.

Which has the higher profit margins, Johnson & Johnson or Natera?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and -5.7% for Natera, and the operating margin – and -9.0%. Revenue was $99.3B and $2.9B.

Which is the better investment, Johnson & Johnson or Natera?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.